Does LIFITEGRAST Cause Product prescribing issue? 27 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Product prescribing issue have been filed in association with LIFITEGRAST (Xiidra). This represents 0.2% of all adverse event reports for LIFITEGRAST.
27
Reports of Product prescribing issue with LIFITEGRAST
0.2%
of all LIFITEGRAST reports
0
Deaths
11
Hospitalizations
How Dangerous Is Product prescribing issue From LIFITEGRAST?
Of the 27 reports, 11 (40.7%) required hospitalization.
Is Product prescribing issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LIFITEGRAST. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does LIFITEGRAST Cause?
Eye irritation (2,486)
Vision blurred (2,465)
Drug ineffective (1,373)
Instillation site pain (1,281)
Dysgeusia (1,067)
Eye pain (1,032)
Instillation site reaction (1,019)
Dry eye (1,013)
Ocular hyperaemia (570)
Lacrimation increased (547)
What Other Drugs Cause Product prescribing issue?
DUPILUMAB (1,715)
POLYETHYLENE GLYCOL 3350 (1,439)
LENALIDOMIDE (948)
OXYCODONE (646)
RIVAROXABAN (359)
ACETAMINOPHEN\OXYCODONE (347)
ETONOGESTREL (311)
ACETAMINOPHEN\HYDROCODONE (298)
CERTOLIZUMAB PEGOL (297)
CABOZANTINIB S-MALATE (294)
Which LIFITEGRAST Alternatives Have Lower Product prescribing issue Risk?
LIFITEGRAST vs LIMAPROST
LIFITEGRAST vs LINACLOTIDE
LIFITEGRAST vs LINAGLIPTIN
LIFITEGRAST vs LINAGLIPTIN\METFORMIN
LIFITEGRAST vs LINCOMYCIN